[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370441-105":59,"doc-detail-370441-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","towards-a-better-registration-of-neuroendocrine-neoplasms-the-results-of-the-italian-retrospective-population-based-study","Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study","","Background: The increasing incidence, evolving classification, rarity, and heterogeneity of neuroendocrine neoplasms (NENs) challenge registration, especially in separating neuroendocrine carcinoma (NEC) from neuroendocrine tumours (NETs). Methods: A pilot study reviewed gastroenteropancreatic (GEP) neuroendocrine carcinomas not otherwise specified (NOS) (ICD-O3 8246) from 2012–2020 across cancer registries. Results: Only 31% of GEP NOS carcinomas were confirmed; 50% were recoded as NETs, and ~17% were non-NENs. Incidence rates and relative NET/NEC patterns were estimated. Conclusion: GEP NEN, NET, and NEC incidence in participating Italian registries matched other European findings.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/towards-a-better-registration-of-neuroendocrine-neoplasms-the-results-of-the-italian-retrospective-population-based-study/370441/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/towards-a-better-registration-of-neuroendocrine-neoplasms-the-results-of-the-italian-retrospective-population-based-study/370441.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does NEN registration require special attention in Italy?","Question",{"text":112,"@type":113},"Rising incidence, rapidly evolving classification, rarity, and heterogeneity make it difficult to distinguish neuroendocrine carcinoma (NEC) from neuroendocrine tumours (NETs), and this affects registry accuracy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the pilot study review and how were cases handled?",{"text":117,"@type":113},"The study examined gastroenteropancreatic neuroendocrine carcinomas NOS (ICD-O3 8246) from 2012–2020. Participating cancer registries reviewed pathology-report information to confirm whether cases should be registered as NEC NOS, NET, or non-NENs.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings after registry review?",{"text":121,"@type":113},"After review, only 31% of GEP NOS neuroendocrine carcinomas were confirmed; 50% were recoded as NETs, and about 17% were non-NENs. The study also estimated incidence rates for GEP NENs and for NETs versus NECs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370441,1790427398,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Original Research Article  \nTj  \nTumori journal  \nTowards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study  \nTumori Journal  \n2025, Vol. 111(2) 133–138 © Fondazione IRCCS Istituto Nazionale dei Tumori 2025  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03008916251317128](DOI: 10.1177/03008916251317128)[ ](DOI: 10.1177/03008916251317128)[journals.sagepub.com/home/tmj](journals.sagepub.com/home/tmj)  \nAnnalisa Trama 1, Francesco Cuccaro2, Domenico Damiani3,  \nAlice Bernasconi 1, Francesco Panzuto4, Nicola Fazio5, Simona Carone6, Maria Giovanna Burgio Lo Monaco7, Rossella Bruni7, Adele Caldarella8, Annalisa Roselli8, Barbara Cortini8, Rosalba Amodio9, Walter Mazzucco9, Silvia Leite 10, Chiara Lupi 11, Maddalena Baracco 12, Eva Carpin 12, Antonella Dal Cin 12, Annarita Fiore 12, Laura Memo 12, Stefano Guzzinati 12, Antonietta Alfia Maria Torrisi 13, Antonina Torrisi 13, Margherita Ferrante 13, Maria Teresa Pesce 14, Alessandra Sessa 14, Antonietta Minichino 14,  \nNadia Di Pascale 14, Maria Francesca Vitale 15, Mario Fusco 15, Ilaria Girolami3, Massimo Milione 16\\# and Fabrizio Stracci 10, 11, 17\\# on behalf of AIRTum and Itanet  \nAbstract  \nBackground: The increasing incidence, rapidly evolving classification, rarity and heterogeneity of neuroendocrine neoplasms (NENs) pose challenges to NEN registration including difficulty in distinguishing neuroendocrine carcinoma (NEC) and neuroendocrine tumours (NETs). Thus, in Italy a higher NEC incidence was reported. Focusing ongastroenteropancreatic (GEP) NEN, we aimed to review GEP NEN, and in particular cases of neuroendocrine carcinoma, not otherwise specified (NOS) and estimate the incidence of NEN, NET and NEC of the GEP.  \nMethods: We launched a pilot study examining cases of neuroendocrine carcinomas NOS (ICD-O3 code 8246) of GEP incidents in the years 2012-2020. Cancer registries (CRs) reviewed information included in the pathology report  \n1 Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy  \n2Puglia Cancer Registry, Section of Local Health Authority BarlettaAndria-Trani, Barletta, Italy  \n3Department of Pathology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, via Lorenz Böhler, 5, 39100 Bolzano-Bozen, Italy. 4Department of Medical-Surgical Sciences and Translational Medicine, Digestive Disease Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy 5Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IRCCS European Institute of Oncology (IEO), Milan, Italy 6Puglia Cancer Registry, Section of Local Health Authority Taranto, Taranto, Italy  \n7Puglia Cancer Registry, Coordination Centre, Strategic Regional Agency for Health and Social Care-Puglia, Bari, Italy  \n8Tuscany Cancer Registry, Clinical Epidemiology Unit Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy 9Clinical Epidemiology and Cancer Registry Unit, Azienda Ospedaliera Universitaria Policlinico, Palermo, Italy  \n10Cancer Registry of Umbria, Punto Zero, Perugia, Italy  \n11 School of Public Health, Department of Medicine, University of Perugia, Perugia, Italy  \n12Veneto Tumour Registry, Epidemiological Department, Azienda Zero, Padova, Italy  \n13Cancer Registry Catania-Messina-Enna, G. Rodolico – San Marco Polyclinic University Hospital, Catania, Italy  \n14ASL Caserta-U.O.C. Monitoraggio rischio ambientale e Registro Tumori, Caserta, Italy  \n15Napoli 3 Sud Cancer Registry, Brusciano, Italy  \n16 1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 17Public Health Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy  \n\\#These authors contribu","cbCaieKysHUmEhhh","https://ap.wps.com/l/cbCaieKysHUmEhhh","pdf",456407,"English","# Abstract\n# Background\n# Methods\n## Pilot study design and case review\n## Coding and incidence estimation\n# Results\n# Conclusion and Impact","[{\"question\":\"Why does NEN registration require special attention in Italy?\",\"answer\":\"Rising incidence, rapidly evolving classification, rarity, and heterogeneity make it difficult to distinguish neuroendocrine carcinoma (NEC) from neuroendocrine tumours (NETs), and this affects registry accuracy.\"},{\"question\":\"What did the pilot study review and how were cases handled?\",\"answer\":\"The study examined gastroenteropancreatic neuroendocrine carcinomas NOS (ICD-O3 8246) from 2012–2020. Participating cancer registries reviewed pathology-report information to confirm whether cases should be registered as NEC NOS, NET, or non-NENs.\"},{\"question\":\"What were the key findings after registry review?\",\"answer\":\"After review, only 31% of GEP NOS neuroendocrine carcinomas were confirmed; 50% were recoded as NETs, and about 17% were non-NENs. The study also estimated incidence rates for GEP NENs and for NETs versus NECs.\"}]","Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study | PDF",1790188514,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a7257a2ccd054844a2b01d1a5e1231b.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3990a2fb669cafedc0db22a9b61a933b.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17c7c9014d8444bc1a9278da0c09e25d.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b02dee1b8c82efef084996f536e301c.webp",980,1306]